Insider Transactions in Q1 2023 at Bioventus Inc. (BVS)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 24
2023
|
Mark Leonard Singleton SVP & CFO |
SELL
Open market or private sale
|
Direct |
6,044
-32.45%
|
$6,044
$1.27 P/Share
|
|
Mar 21
2023
|
Mark Leonard Singleton SVP & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
18,625
+50.0%
|
-
|
|
Mar 15
2023
|
Kenneth Michael Reali Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
9,811
-24.59%
|
$9,811
$1.39 P/Share
|
|
Mar 15
2023
|
Anthony D'Adamio SVP & General Counsel |
SELL
Open market or private sale
|
Direct |
3,409
-6.95%
|
$3,409
$1.39 P/Share
|
|
Mar 15
2023
|
Katrina J Church SVP & Chief Compliance Officer |
SELL
Open market or private sale
|
Direct |
1,332
-22.36%
|
$1,332
$1.39 P/Share
|
|
Mar 14
2023
|
Kenneth Michael Reali Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
28,721
+41.86%
|
-
|
|
Mar 14
2023
|
William A Hawkins Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,949
+3.94%
|
-
|
|
Mar 14
2023
|
Anthony D'Adamio SVP & General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
8,887
+15.35%
|
-
|
|
Mar 14
2023
|
Katrina J Church SVP & Chief Compliance Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,456
+36.72%
|
-
|